ArticleBMC public health2025
Community-based evaluation of cardiovascular risk using QRISK
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Translation, Reliability, Psychometric Validation, and Confirmatory Factor Analysis of the Urdu Version of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS-U) Among Hypertensive Patients in Lahore, Pakistan: A Validation Study.Health science reports · 2026Article
- Risk estimation of cardiovascular disease in Qatar's primary care settings: application of QRISK3 algorithm and sociodemographic predictors.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCardiovascular disease (CVD) rates are rising rapidly among Indians with type 2 diabetes mellitus (T2DM). This study compared two cardiovascular risk assessment tools - QRISK
methodsWe conducted a cross-sectional study in 600 T2DM patients aged 25-84 years recruited from urban and rural areas of the Jamnagar district using stratified random sampling. Sociodemographic details, anthropometrics, and fasting blood tests were recorded. QRISK
resultsThe mean age was 55 ± 8.5 years, and 60% were male. Using QRISK
conclusionBoth scoring systems showed substantial agreement in risk classification, with better concordance in older age groups. LAI risk score classified more younger patients as high-risk and weighted smoking and family history more heavily than QRISK
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.